Clinical Trial Update: Next-Gen MS: Feed-forward PRO Data for MS Research

View source ↗

Summary

Clinical trial NCT04907305 investigating next-generation patient-reported outcomes data for multiple sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Multiple Sclerosis (MS) | Status: TERMINATED